<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Although many studies have shown that administration of stem cells after focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> improves brain damage, very little data are available concerning the damage induced by global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The latter causes neuronal <z:hpo ids='HP_0011420'>death</z:hpo> in selectively vulnerable areas, including the hippocampal CA1 region </plain></SENT>
<SENT sid="2" pm="."><plain>We tested the hypothesis that intravenous infusion of bone marrowderived stromal cells (mesenchimal stem cells, MSC) reduce brain damage after transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>In adult male Sprague-Dawley rats transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> was induced using bilateral common carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 20â€‰min in addition to controlled <z:hpo ids='HP_0002615'>hypotension</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Five days after, the animals were anaesthetized with <z:chebi fb="5" ids="17967">urethane</z:chebi> and the brain was fixed, sectioned and stained with <z:chebi fb="1" ids="51686">hematoxylin</z:chebi>-eosin to investigate histological damage </plain></SENT>
<SENT sid="5" pm="."><plain>MSC did not fully protect against ischemic damage, as the number of viable neurons in this group was lower than in <z:mpath ids='MPATH_458'>normal</z:mpath> (sham-operated) rats </plain></SENT>
<SENT sid="6" pm="."><plain>However, in MSC-treated rats the number of viable CA1 pyramidal neurons was significally higher than in rats that had been subjected to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> but not treated with MSC </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that intravenous administration of MSC after transient global <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> reduces hippocampal damage </plain></SENT>
</text></document>